These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1075 related items for PubMed ID: 32969881
1. Clinical Decision Support for High-Risk Stage II Colon Cancer: A Real-World Study of Treatment Concordance and Survival. Chen PJ, Li TL, Sun TT, Willis VC, Roebuck MC, Bravata DM, Liu XZ, Arriaga YE, Dankwa-Mullan I, Wu AW. Dis Colon Rectum; 2020 Oct; 63(10):1383-1392. PubMed ID: 32969881 [Abstract] [Full Text] [Related]
2. Is Microsatellite Status Associated With Prognosis in Stage II Colon Cancer With High-Risk Features? Cavallaro PM, Stafford C, Cauley CE, Berger DL, Bordeianou L, Kunitake H, Francone T, Ricciardi R. Dis Colon Rectum; 2021 May; 64(5):545-554. PubMed ID: 33939386 [No Abstract] [Full Text] [Related]
3. A Population-Based Cohort Study of Venous Thromboembolism Rates Following Surgery and During Adjuvant Chemotherapy in Patients With Colon Cancer. Patel SV, Zhang L, Wei XS, Merchant SJ, Nanji S, James PD, Booth CM. Dis Colon Rectum; 2020 Mar; 63(3):336-345. PubMed ID: 32045399 [Abstract] [Full Text] [Related]
4. Multiple High-Risk Features for Stage II Colon Carcinoma Portends Worse Survival Than Stage III Disease. Hajirawala LN, Yi Y, Herritt BC, Laurent ME, Klinger AL, Orangio GR, Davis KG, Barton JS. Dis Colon Rectum; 2023 Aug 01; 66(8):1076-1084. PubMed ID: 35239528 [Abstract] [Full Text] [Related]
5. Age Determines Adjuvant Chemotherapy Use in Resected Stage II Colon Cancer. Hagerty BL, Aversa JG, Dominguez DA, Davis JL, Hernandez JM, McCormick JT, Blakely AM. Dis Colon Rectum; 2022 Oct 01; 65(10):1206-1214. PubMed ID: 34897212 [No Abstract] [Full Text] [Related]
6. Adjuvant Chemotherapy Does Not Improve Recurrence-Free Survival in Patients With Stage 2 or Stage 3 Rectal Cancer After Neoadjuvant Chemoradiotherapy and Total Mesorectal Excision. Voss RK, Lin JC, Roper MT, Al-Temimi MH, Ruan JH, Tseng WH, Tam M, Sherman MJ, Klaristenfeld DD, Tomassi MJ. Dis Colon Rectum; 2020 Apr 01; 63(4):427-440. PubMed ID: 31996583 [Abstract] [Full Text] [Related]
7. Is High-Grade Tumor Budding an Independent Prognostic Factor in Stage II Colon Cancer? Kyong Shin J, Ah Park Y, Wook Huh J, Hyeon Yun S, Cheol Kim H, Yong Lee W, Hyung Kim S, Yun Ha S, Cho YB. Dis Colon Rectum; 2023 Aug 01; 66(8):e801-e808. PubMed ID: 35394982 [Abstract] [Full Text] [Related]
8. Perineural Invasion Is a Prognostic but not a Predictive Factor in Nonmetastatic Colon Cancer. Leijssen LGJ, Dinaux AM, Taylor MS, Deshpande V, Kunitake H, Bordeianou LG, Berger DL. Dis Colon Rectum; 2019 Oct 01; 62(10):1212-1221. PubMed ID: 31490830 [Abstract] [Full Text] [Related]
9. Prognostic Value of Venous Invasion Detected by Elastin Stain May Surpass Lymph Node Status in Colon Cancer. Kim HJ, Choi GS, Seo AN, Park JS, Park SY, Cho SH, Yoon G. Dis Colon Rectum; 2021 Aug 01; 64(8):955-963. PubMed ID: 33938533 [Abstract] [Full Text] [Related]
10. Factors Associated With Adjuvant Chemotherapy Noncompliance and Survival in Older Adults With Stage III Colon Cancer. Simon HL, Reif de Paula T, Spigel ZA, Keller DS. Dis Colon Rectum; 2023 Sep 01; 66(9):1254-1262. PubMed ID: 36574320 [Abstract] [Full Text] [Related]
11. Patterns of Care and Comparison of Outcomes Between Primary Anal Squamous Cell Carcinoma and Anal Adenocarcinoma. Malakhov N, Kavi AM, Lee A, Adedoyin P, Sheth N, Lederman AJ, Schreiber D. Dis Colon Rectum; 2019 Dec 01; 62(12):1448-1457. PubMed ID: 31725581 [Abstract] [Full Text] [Related]
12. Perirenal Fat Surface Area and Oncologic Outcome in Elective Colon Cancer Surgery. Eckberg SE, Dahlberg MJA, der Hagopian OS, Farahnak P, Sandblom GK, Nordenvall CAM, Everhov ÅH. Dis Colon Rectum; 2021 Feb 01; 64(2):171-180. PubMed ID: 33315716 [Abstract] [Full Text] [Related]
13. Predictors and Outcomes of Upstaging in Rectal Cancer Patients Who Did Not Receive Preoperative Therapy. Antunez AG, Kanters AE, Regenbogen SE. Dis Colon Rectum; 2023 Jan 01; 66(1):59-66. PubMed ID: 35905174 [Abstract] [Full Text] [Related]
14. Is There a Role for Neoadjuvant Systemic Therapy for cT4bM0 Colon Cancer? A Propensity Score-Matched Analysis of the National Cancer Database. Kamel MK, Shchatsko A, Keane CA, Serpa E, Al-Qudah G, Rahouma M, Nituica C, Blebea J, Marar O. Dis Colon Rectum; 2023 Nov 01; 66(11):1435-1448. PubMed ID: 36876973 [Abstract] [Full Text] [Related]
15. Differential Survival Benefits of 5-Fluorouracil-Based Adjuvant Chemotherapy for Patients With Microsatellite-Stable Stage III Colorectal Cancer According to the Tumor Budding Status: A Retrospective Analysis. Yamadera M, Shinto E, Kajiwara Y, Mochizuki S, Okamoto K, Hase K, Yamamoto J, Ueno H. Dis Colon Rectum; 2019 Nov 01; 62(11):1316-1325. PubMed ID: 31567925 [Abstract] [Full Text] [Related]
16. Does IBD Portend Worse Outcomes in Patients with Rectal Cancer? A Case-Matched Analysis. Alsughayer A, Grass F, McKenna NP, Petersen M, Mathis KL, Lightner AL. Dis Colon Rectum; 2020 Sep 01; 63(9):1265-1275. PubMed ID: 33216497 [Abstract] [Full Text] [Related]
17. Patient Survival With ypT0N+ Following Neoadjuvant Therapy in Rectal Cancer. Elshami M, Goldstone RN, Blaszkowsky LS, Cusack JC, Hong TS, Wo JY, Qadan M. Dis Colon Rectum; 2022 Oct 01; 65(10):1224-1231. PubMed ID: 35714358 [Abstract] [Full Text] [Related]
18. Association of a Preoperative Leisure-Time Physical Activity With Short- and Long-term Outcomes of Patients Undergoing Curative Resection for Stage I to III Colorectal Cancer: A Propensity Score Matching Analysis. You JF, Hsu YJ, Chern YJ, Hung HY, Hsieh PS, Yeh CY, Chiang JM, Tsai WS. Dis Colon Rectum; 2020 Jun 01; 63(6):796-806. PubMed ID: 32118625 [Abstract] [Full Text] [Related]